BioNTech SE (BNTX) Cash from Investing Activities (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Cash from Investing Activities data on file, last reported at -$3.2 billion in Q4 2025.

• In Q4 2025, Cash from Investing Activities fell 589.38% year-over-year to -$3.2 billion; the TTM figure through Dec 2025 stood at -$2.9 billion (down 29.47% YoY), while the FY2025 annual figure was -$2.8 billion, down 25.4% from the prior year.
• Cash from Investing Activities declined to -$3.2 billion in Q4 2025, from $648.3 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $648.3 million in Q4 2024 and bottomed at -$3.2 billion in Q4 2025.
• A 5-year average of -$898.1 million and a median of -$208.0 million in 2024 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2021 — Cash from Investing Activities jumped 96043426.27% — and 2023, when it slumped 1865.35%.
• Year by year, Cash from Investing Activities stood at $114.3 million in 2021, then surged by 43.73% to $164.3 million in 2022, then tumbled by 1865.35% to -$2.9 billion in 2023, then jumped by 122.36% to $648.3 million in 2024, then slumped by 589.38% to -$3.2 billion in 2025.
• The last three Cash from Investing Activities figures came in at -$3.2 billion (Q4 2025), $648.3 million (Q4 2024), and -$156.1 million (Q3 2024), per Business Quant data.

Peer Comparison